Your browser doesn't support javascript.
loading
Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.
Khoza, Leon J; Kumar, Pradeep; Dube, Admire; Demana, Patrick H; Choonara, Yahya E.
Afiliação
  • Khoza LJ; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Parktown 2193, South Africa.
  • Kumar P; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Parktown 2193, South Africa.
  • Dube A; School of Pharmacy, Faculty of Natural Sciences, University of the Western Cape, Cape Town, South Africa.
  • Demana PH; Division of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.
  • Choonara YE; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Parktown 2193, South Africa. Electronic address: yahya.choonara@wits.ac.za.
Int J Pharm ; 622: 121893, 2022 06 25.
Article em En | MEDLINE | ID: mdl-35680110

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Nanopartículas / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Nanopartículas / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2022 Tipo de documento: Article